Survival analyses revealed that lower ABAT mRNA expression was correlated with poor OS in patients with HCC (P = 0.002) (Figure 3A), consistent with the qRT-PCR data (P = 0.0093) (Figure 3B). This evidence concerns the gene ABAT and hepatocellular carcinoma.